An 8-Month Systems Toxicology Inhalation/Cessation Study in Apoe−/− Mice to Investigate Cardiovascular and Respiratory Exposure Effects of a Candidate Modified Risk Tobacco Product, THS 2.2, Compared With Conventional Cigarettes

Smoking cigarettes is a major risk factor in the development and progression of cardiovascular disease (CVD) and chronic obstructive pulmonary disease (COPD). Modified risk tobacco products (MRTPs) are being developed to reduce smoking-related health risks. The goal of this study was to investigate hallmarks of COPD and CVD over an 8-month period in apolipoprotein E-deficient mice exposed to conventional cigarette smoke (CS) or to the aerosol of a candidate MRTP, tobacco heating system (THS) 2.2. In addition to chronic exposure, cessation or switching to THS2.2 after 2 months of CS exposure was assessed. Engaging a systems toxicology approach, exposure effects were investigated using physiology and histology combined with transcriptomics, lipidomics, and proteomics. CS induced nasal epithelial hyperplasia and metaplasia, lung inflammation, and emphysematous changes (impaired pulmonary function and alveolar damage). Atherogenic effects of CS exposure included altered lipid profiles and aortic plaque formation. Exposure to THS2.2 aerosol (nicotine concentration matched to CS, 29.9 mg/m3) neither induced lung inflammation or emphysema nor did it consistently change the lipid profile or enhance the plaque area. Cessation or switching to THS2.2 reversed the inflammatory responses and halted progression of initial emphysematous changes and the aortic plaque area. Biological processes, including senescence, inflammation, and proliferation, were significantly impacted by CS but not by THS2.2 aerosol. Both, cessation and switching to THS2.2 reduced these perturbations to almost sham exposure levels. In conclusion, in this mouse model cessation or switching to THS2.2 retarded the progression of CS-induced atherosclerotic and emphysematous changes, while THS2.2 aerosol alone had minimal adverse effects.

[1]  Yang Xiang,et al.  Quantification of biological network perturbations for mechanistic insight and diagnostics using two-layer causal models , 2014, BMC Bioinformatics.

[2]  Susan E. Wrenn,et al.  Smoke chemistry, in vitro and in vivo toxicology evaluations of the electrically heated cigarette smoking system series K. , 2008, Regulatory toxicology and pharmacology : RTP.

[3]  Office on Smoking.  How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General , 2010 .

[4]  A. Daugherty,et al.  Atherogenic and pulmonary responses of ApoE- and LDL receptor-deficient mice to sidestream cigarette smoke. , 2012, Toxicology.

[5]  Ashraf Elamin,et al.  A 7-month cigarette smoke inhalation study in C57BL/6 mice demonstrates reduced lung inflammation and emphysema following smoking cessation or aerosol exposure from a prototypic modified risk tobacco product. , 2015, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[6]  Julia Hoeng,et al.  Quantitative assessment of biological impact using transcriptomic data and mechanistic network models. , 2013, Toxicology and applied pharmacology.

[7]  K. Kulkarni,et al.  Cholesterol profile measurement by vertical auto profile method. , 2006, Clinics in laboratory medicine.

[8]  Manuel C. Peitsch,et al.  The Apoe -/- Mouse PhysioLab ® Platform: A Validated Physiologically-based Mathematical Model of Atherosclerotic Plaque Progression in the Apoe -/- Mouse , 2012 .

[9]  R. Strongin,et al.  Hidden formaldehyde in e-cigarette aerosols. , 2015, The New England journal of medicine.

[10]  Julia Hoeng,et al.  A 28-day rat inhalation study with an integrated molecular toxicology endpoint demonstrates reduced exposure effects for a prototypic modified risk tobacco product compared with conventional cigarettes. , 2014, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[11]  Manuel C. Peitsch,et al.  Systems Toxicology: From Basic Research to Risk Assessment , 2014, Chemical research in toxicology.

[12]  A. Papavassiliou,et al.  Smoking and atherosclerosis: mechanisms of disease and new therapeutic approaches. , 2014, Current medicinal chemistry.

[13]  R. Pauwels,et al.  Burden and clinical features of chronic obstructive pulmonary disease (COPD) , 2004, The Lancet.

[14]  Megan E. Piper,et al.  Effects of smoking and smoking cessation on lipids and lipoproteins: outcomes from a randomized clinical trial. , 2011, American heart journal.

[15]  Andrew R. Jones,et al.  ProteomeXchange provides globally co-ordinated proteomics data submission and dissemination , 2014, Nature Biotechnology.

[16]  M. Morris,et al.  Detrimental metabolic effects of combining long-term cigarette smoke exposure and high-fat diet in mice. , 2007, American journal of physiology. Endocrinology and metabolism.

[17]  C. Leroy,et al.  Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 5: 8-Day randomized clinical trial in Japan. , 2012, Regulatory toxicology and pharmacology : RTP.

[18]  M. Peitsch,et al.  Cigarette-smoke-induced atherogenic lipid profiles in plasma and vascular tissue of apolipoprotein E-deficient mice are attenuated by smoking cessation. , 2013, Atherosclerosis.

[19]  Jennifer Park,et al.  Causal biological network database: a comprehensive platform of causal biological network models focused on the pulmonary and vascular systems , 2015, Database J. Biol. Databases Curation.

[20]  P. Vanscheeuwijck,et al.  Toxicological evaluation of an electrically heated cigarette. Part 4: Subchronic inhalation toxicology , 2003, Journal of applied toxicology : JAT.

[21]  Matthias Ochs,et al.  Assessment of air space size characteristics by intercept (chord) measurement: an accurate and efficient stereological approach. , 2010, Journal of applied physiology.

[22]  Julia Hoeng,et al.  Case study: the role of mechanistic network models in systems toxicology. , 2014, Drug discovery today.

[23]  Dirkje S Postma,et al.  Risk factors and early origins of chronic obstructive pulmonary disease , 2015, The Lancet.

[24]  S. Young,et al.  Lipoprotein size and atherosclerosis susceptibility in Apoe(-/-) and Ldlr(-/-) mice. , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[25]  D. O'Connor,et al.  Nicotinic acetylcholine receptors in glucose homeostasis: the acute hyperglycemic and chronic insulin-sensitive effects of nicotine suggest dual opposing roles of the receptors in male mice. , 2014, Endocrinology.

[26]  M. Peitsch,et al.  Cigarette smoke induces molecular responses in respiratory tissues of ApoE(-/-) mice that are progressively deactivated upon cessation. , 2013, Toxicology.

[27]  Julia Hoeng,et al.  A network-based approach to quantifying the impact of biologically active substances. , 2012, Drug discovery today.

[28]  S. Fineschi,et al.  Different lung responses to cigarette smoke in two strains of mice sensitive to oxidants , 2005, European Respiratory Journal.

[29]  I. Rahman,et al.  Emphysema is associated with increased inflammation in lungs of atherosclerosis-prone mice by cigarette smoke: implications in comorbidities of COPD , 2010, Journal of Inflammation.

[30]  Thomas P. Erlinger,et al.  Smoking Cessation and Cardiovascular Disease Risk Factors: Results from the Third National Health and Nutrition Examination Survey , 2005, PLoS medicine.

[31]  Manuel C. Peitsch,et al.  Assessment of network perturbation amplitudes by applying high-throughput data to causal biological networks , 2012, BMC Systems Biology.

[32]  M. Peitsch,et al.  Modulation of atherogenic lipidome by cigarette smoke in apolipoprotein E-deficient mice. , 2012, Atherosclerosis.

[33]  G. Lowe,et al.  Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh Artery Study. , 1999, European heart journal.

[34]  Takwi Nkyimbeng,et al.  Transgenic expression of matrix metalloproteinase-9 causes adult-onset emphysema in mice associated with the loss of alveolar elastin. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[35]  N. Pride,et al.  Smoking cessation in COPD causes a transient improvement in spirometry and decreases micronodules on high-resolution CT imaging. , 2014, Chest.

[36]  M. Ochs.  Estimating structural alterations in animal models of lung emphysema. Is there a gold standard? , 2014, Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft.

[37]  H. Haussmann,et al.  Murine lung tumor response after exposure to cigarette mainstream smoke or its particulate and gas/vapor phase fractions. , 2010, Toxicology.

[38]  Feng Gao,et al.  Optimization of MicroCT Imaging and Blood Vessel Diameter Quantitation of Preclinical Specimen Vasculature with Radiopaque Polymer Injection Medium , 2011, PloS one.

[39]  W. Scherle,et al.  A simple method for volumetry of organs in quantitative stereology. , 1970, Mikroskopie.

[40]  Damian Szklarczyk,et al.  STRING v9.1: protein-protein interaction networks, with increased coverage and integration , 2012, Nucleic Acids Res..

[41]  Douglas A Luke,et al.  Family Smoking Prevention And Tobacco Control Act: banning outdoor tobacco advertising near schools and playgrounds. , 2011, American journal of preventive medicine.

[42]  A. Tricker,et al.  Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 1: Non-clinical and clinical insights. , 2012, Regulatory toxicology and pharmacology : RTP.

[43]  장욱.  미국의 가족금연 및 담배규제법(Family Smoking Prevention and Tobacco Control Act) 제정을 통해 본 우리의 입법과제 , 2009 .

[44]  S. Lebrun,et al.  Progression of atherosclerosis in the Apo E-/- model: 12-month exposure to cigarette mainstream smoke combined with high-cholesterol/fat diet. , 2009, Atherosclerosis.

[45]  H. Haussmann,et al.  Toxicological evaluation of an electrically heated cigarette. Part 2: Chemical composition of mainstream smoke , 2003, Journal of applied toxicology : JAT.